The severity of
burn and
smoke inhalation-induced
acute lung injury (BSI-ALI) is associated with alveolar and interstitial
edema,
bronchospasm, and airway mucosal
hyperemia. Previously, we have reported beneficial effects of
epinephrine nebulization on BSI-ALI. However, the underlying mechanisms of salutary effects of nebulized
epinephrine remain unclear. The present study compared the effects of
epinephrine,
phenylephrine, and
albuterol on a model of BSI-ALI. We tested the hypothesis that both α1- and β2-agonist effects are required for ameliorating more efficiently the BSI-ALI. Forty percent of total body surface area, 3rd-degree cutaneous
burn, and 48-breaths of cotton
smoke inhalation were induced to 46 female Merino sheep. Postinjury, sheep were mechanically ventilated and cardiopulmonary hemodynamics were monitored for 48 h. Sheep were allocated into groups: control, n = 17;
epinephrine, n = 11;
phenylephrine, n = 6; and
albuterol, n = 12. The drug nebulization began 1 h postinjury and was repeated every 4 h thereafter. In the results,
epinephrine group significantly improved oxygenation compared to other groups, and significantly reduced pulmonary vascular permeability index,
lung wet-to-dry weight ratio, and lung tissue growth factor-β1 level compared with
albuterol and control groups.
Epinephrine and
phenylephrine groups significantly reduced trachea wet-to-dry weight ratio and lung
vascular endothelial growth factor-A level compared with control group. Histopathologically,
epinephrine group significantly reduced lung severity scores and preserved
vascular endothelial-cadherin level in pulmonary arteries. In conclusion, the results of our studies suggest that nebulized
epinephrine more effectively ameliorated the severity of BSI-ALI than
albuterol or
phenylephrine, possibly by its combined α1- and β2-agonist properties.